TR200100107T2 - Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. - Google Patents
Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.Info
- Publication number
- TR200100107T2 TR200100107T2 TR2001/00107T TR200100107T TR200100107T2 TR 200100107 T2 TR200100107 T2 TR 200100107T2 TR 2001/00107 T TR2001/00107 T TR 2001/00107T TR 200100107 T TR200100107 T TR 200100107T TR 200100107 T2 TR200100107 T2 TR 200100107T2
- Authority
- TR
- Turkey
- Prior art keywords
- polymer
- pharmaceutical form
- active ingredient
- programmed
- preparation
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bulus, aktif bilesenin saliniminin gecikmeli ve fasilali oldugu ve farmasötik formun alinmasindan sonra 4 ila 8 saat içinde aktif bilesenin kullanilabilmesini saglayan, ve daha sonra takip eden 8 ila 20 saat içinde aktif bilesenin tümünün sürekli olarak salinmasini saglayan bulusa göre olan çok parçacikli farmasötik form ile ilgilidir, ki özelligi organik asit içermemesi, ve içinde aktif bileseni olusturan parçaciklarin esit olarak dagildigi en az bir hidro-çözünebilir polimer ve en az bir hidro-çözünebilir olmayan polimer karisimina dayanan bir birinci kaplama içeren bir nötr küresel çekirdek, gastrik ve intestinel ortamlara göre birbirinden farkli geçirgenlik hizlari saglayan en az iki pH bagimsiz polimere, en az bir pH bagimli polimere, en az bir plastiklestiriciye ve esit olarak dagilmis en az bir inert tasiyiciya dayanan bir ikinci kaplama içeren tibbi küreler formunda olmasidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9806384A FR2778848B1 (fr) | 1998-05-20 | 1998-05-20 | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100107T2 true TR200100107T2 (tr) | 2001-06-21 |
Family
ID=9526556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00107T TR200100107T2 (tr) | 1998-05-20 | 1999-05-20 | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1077687B1 (tr) |
JP (1) | JP2002515423A (tr) |
KR (1) | KR100583065B1 (tr) |
CN (1) | CN1186014C (tr) |
AT (1) | ATE214598T1 (tr) |
AU (1) | AU758299B2 (tr) |
BG (1) | BG64764B1 (tr) |
BR (1) | BR9910606A (tr) |
CA (1) | CA2333188C (tr) |
DE (1) | DE69901062T2 (tr) |
DK (1) | DK1077687T3 (tr) |
ES (1) | ES2173739T3 (tr) |
FR (1) | FR2778848B1 (tr) |
GE (1) | GEP20022750B (tr) |
HU (1) | HU224193B1 (tr) |
IL (1) | IL139774A (tr) |
MX (1) | MXPA00011364A (tr) |
NO (1) | NO330501B1 (tr) |
NZ (1) | NZ508392A (tr) |
PL (1) | PL192950B1 (tr) |
PT (1) | PT1077687E (tr) |
TR (1) | TR200100107T2 (tr) |
WO (1) | WO1999059557A1 (tr) |
ZA (1) | ZA200006768B (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
WO2004112756A1 (en) | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
WO2006047493A2 (en) | 2004-10-21 | 2006-05-04 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US9161918B2 (en) * | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
AU2013273835B2 (en) * | 2005-05-02 | 2016-07-07 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2008136016A1 (en) * | 2007-05-08 | 2008-11-13 | Medreich Limited | A stable controlled release oral solid dosage form composition and a process thereof |
ES2668203T3 (es) | 2009-12-02 | 2018-05-17 | Adare Pharmaceuticals S.R.L. | Microcápsulas de fexofenadina y composiciones que las contienen |
FR2999432B1 (fr) | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
FR2754710B1 (fr) * | 1996-10-22 | 1998-12-31 | Prographarm Lab | Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle |
-
1998
- 1998-05-20 FR FR9806384A patent/FR2778848B1/fr not_active Expired - Lifetime
-
1999
- 1999-05-20 JP JP2000549222A patent/JP2002515423A/ja active Pending
- 1999-05-20 MX MXPA00011364A patent/MXPA00011364A/es active IP Right Grant
- 1999-05-20 TR TR2001/00107T patent/TR200100107T2/tr unknown
- 1999-05-20 AT AT99920897T patent/ATE214598T1/de active
- 1999-05-20 GE GEAP19995632A patent/GEP20022750B/en unknown
- 1999-05-20 HU HU0102027A patent/HU224193B1/hu active IP Right Grant
- 1999-05-20 CA CA2333188A patent/CA2333188C/fr not_active Expired - Lifetime
- 1999-05-20 BR BR9910606-0A patent/BR9910606A/pt not_active Application Discontinuation
- 1999-05-20 AU AU38302/99A patent/AU758299B2/en not_active Expired
- 1999-05-20 EP EP99920897A patent/EP1077687B1/fr not_active Expired - Lifetime
- 1999-05-20 ES ES99920897T patent/ES2173739T3/es not_active Expired - Lifetime
- 1999-05-20 DE DE69901062T patent/DE69901062T2/de not_active Expired - Lifetime
- 1999-05-20 CN CNB998074322A patent/CN1186014C/zh not_active Expired - Lifetime
- 1999-05-20 PT PT99920897T patent/PT1077687E/pt unknown
- 1999-05-20 WO PCT/FR1999/001201 patent/WO1999059557A1/fr active IP Right Grant
- 1999-05-20 DK DK99920897T patent/DK1077687T3/da active
- 1999-05-20 KR KR1020007013020A patent/KR100583065B1/ko not_active Expired - Fee Related
- 1999-05-20 PL PL344314A patent/PL192950B1/pl unknown
- 1999-05-20 IL IL13977499A patent/IL139774A/xx not_active IP Right Cessation
- 1999-05-20 NZ NZ508392A patent/NZ508392A/xx not_active IP Right Cessation
-
2000
- 2000-11-17 BG BG104963A patent/BG64764B1/bg unknown
- 2000-11-17 NO NO20005838A patent/NO330501B1/no not_active IP Right Cessation
- 2000-11-20 ZA ZA200006768A patent/ZA200006768B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100107T2 (tr) | Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. | |
KR950702409A (ko) | 방출 조절 모르핀 제제(controlled release morphine preparation) | |
AU2001239658A1 (en) | Method for producing a controlled-release preparation | |
CA2292586A1 (en) | Solid pharmaceutical dosage forms in form of a particulate dispersion | |
AU7495596A (en) | Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process | |
HUP0004732A2 (hu) | Kapszulázási eljárás | |
TR199901564T2 (tr) | Hizli çözülebilen ve tat-maskesi saglayan dozaj ispençiyari formu. | |
FR2775435B1 (fr) | Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs | |
DE69937650D1 (de) | Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe | |
ATE288259T1 (de) | Verfahren zur herstellung fester oraler darreichungsformen mit retardierender wirkstofffreisetzung | |
TR200200966T1 (tr) | Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri | |
ATE204747T1 (de) | Retard-matrixpellets und verfahren zu ihrer herstellung | |
DE60036874D1 (de) | Pellet formulierung mit gesteuerter freisetzung | |
DE3850826D1 (de) | Polymere, nichtwässerige Dispersionen, Verfahren zu deren Herstellung und Beschichtungszusammensetzungen. | |
EP1397200A1 (de) | Auflösbare nano- und mikrokapseln, verfahren zu ihrer herstellung sowie ihre verwendung | |
AU574220B2 (en) | Sustained release drug in ter polymer coat (pvc and pvacand pvom) | |
EP0113776A1 (en) | Quinidine sustained release dosage formulation | |
CA2163539A1 (en) | N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes | |
DK1417960T3 (da) | Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf | |
TR199800344T1 (tr) | Organik asit esasli süzülebilir granülatlar, üretim usulleri. | |
FR2791569B1 (fr) | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention | |
ATE364403T1 (de) | Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden | |
DE59410133D1 (de) | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung | |
WO2001040274A3 (en) | Inhibition of hrsv membrane fusion | |
ATE380018T1 (de) | Verfahren zur herstellung von wirkstoffhaltigen pellets |